USFDA concludes cGMP audit at Cohance Lifesciences’ API manufacturing plant
Cohance Lifesciences, formerly Suven Pharmaceuticals has announced completion of a general current Good Manufacturing Practices…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cohance Lifesciences
Cohance Lifesciences announces ₹230 mn investment and progress on cGMP Oligonucleotide facility at…
Integrated with a pilot plant for early-stage synthesis and for non-GMP scale-up, the facility will add fit-for-purpose GMP…
Cohance Lifesciences appoints Yann D’Herve as CEO of CDMO business
Former Evonik executive to lead Cohance’s integrated platform with focus on APIs, ADCs, and Nucleic Acid Chemistry
Cohance Lifesciences, Suven Pharmaceuticals merger sanctioned by the NCLT
The Company expects to complete the amalgamation process by Q1FY26
Cohance, Suven merger get approval from NSE and BSE
The newly formed company will operate three main verticals: Pharma CDMO, Agrochemicals CDMO, and API manufacturing
Suven, Cohance announce merger
The merged platform to comprise three distinct business units – Pharma CDMO, Spec Chem CDMO, and API+ (inclusive of formulations)
Advent International launches Cohance Lifesciences
Cohance Lifesciences is a new brand identity for Advent International's API platform